Heterologous immunization is the condition in which exposure to or infection with one pathogen can induce or alter the immune response to another unrelated pathogen. Heterologous immunization can alter (enhance or weaken) protective immunity against pathogens, and/or induce severe immunopathology or tolerance to self-antigens. Heterologous immunization plays an important role in the study of the immune process, DNA immunization, and vaccine development.
Heterologous immunization can polarize the immune response to an incoming pathogen by altering the innate immune environment. Simultaneous coinfection may lead to increased viral load and enhanced immunopathology. In addition, primary infection or injury leads to the maturation of antigen-presenting cells, which enhances antigen presentation. It has been shown that suppression or enhancement of the immune response by concurrent infections can have protective or pathogenic effects, depending on the specific characteristics of the individual pathogen and the time interval between the two infections.
CD4 T cells play a crucial role in protection against viral infection and in the development of memory B cells and CD8 T cells. CD4 T cells can protect or exacerbate the infectious process under heterologous immune conditions.
DNA immunization is widely used in the production of antibodies and vaccines. Compared with the traditional immunization route, the DNA immunization method can rapidly, economically, and stably express immunogen in large quantities, which makes it widely used. Common DNA immunization strategies include gene gun DNA immunization, heterologous immunization, electroporation DNA immunization, and naked DNA immunization. Different strategies have different characteristics. The preparation process of naked DNA is simple and the immune effect is good, but the immune effect on large animals is not ideal. Heterologous immunization can make up for this deficiency and obtain a good immune effect.
Anti-TNF therapy can treat many diseases, such as Crohn's disease and rheumatoid arthritis, which is also largely due to the result of heterologous immunization. Our body has a large and complex pool of memory T cells, making it possible to cross-react with any new pathogen and mediate heterologous protective immunity.
Heterologous immunization also plays an important role in the design of vaccines. An important manifestation of heterologous immunity is cross-reactivity. It has been demonstrated that cross-reactive memory T cells have been shown to be directly related to disease severity in the heterologous challenge, and the mutating epitopes presenting this reactivity improve infection outcomes.
Heterologous immunization is a major problem in tolerance induction. The previous infection history in the transplant recipient can be used to control the response to alloantigens, which can be used to design methods for optimal graft survival. Serial infection with heterologous viruses increases the incidence of alloantigen-specific T cells, resulting in the generation of large numbers of memory cells that need to be tolerated before engraftment. It has been reported that anti-CD25, rapamycin, and blocking mAb against the common gamma chain all act synergistically with costimulatory blockade to inhibit allograft rejection.
Creative Biolabs is pleased to share our expertise and experience in heterologous immunization to facilitate our clients' research.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.